Oxidative stress and vein graft failure: a focus on NADH oxidase, nitric oxide and eicosanoids

Helen Weaver1, Nilima Shukla, David Ellinsworth

  • 1Bristol Heart Institute, University of Bristol, UK.

Insights

Superoxide and NADPH oxidase upregulation contribute to vein graft failure by promoting vascular smooth muscle cell proliferation and migration. Inhibiting NADPH oxidase may offer therapeutic strategies for preventing graft thickening.

Area of Science:

  • Cardiovascular Science
  • Vascular Biology
  • Biochemistry

Background:

  • Vein graft failure is a significant clinical challenge.
  • Superoxide and NADPH oxidase upregulation are implicated in graft failure pathogenesis.
  • Mechanisms include endothelial denudation, inflammatory cell factors, hypoxia, and altered eicosanoid signaling.

Purpose of the Study:

  • To review the role of NADPH oxidase in vein graft failure.
  • To discuss the impact of NADPH oxidase on neointima formation and metalloproteinase expression.
  • To explore therapeutic strategies targeting NADPH oxidase.

Main Methods:

  • Literature review focusing on NADPH oxidase in vein graft failure.
  • Analysis of mechanisms leading to NADPH oxidase upregulation.
  • Examination of downstream effects on vascular smooth muscle cells and matrix metalloproteinases.

Main Results:

  • NADPH oxidase upregulation is triggered by multiple factors post-implantation.
  • This leads to vascular smooth muscle cell replication and migration, contributing to neointima formation.
  • Enhanced metalloproteinase expression further drives graft thickening.

Conclusions:

  • NADPH oxidase plays a critical role in the development of vein graft failure.
  • Nitric oxide and eicosanoids are key mediators influenced by NADPH oxidase.
  • Inhibitors of NADPH oxidase activity and expression represent potential therapeutic targets.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...